c-MET-mediated resistance to EGFR inhibitors in head and neck
cancer: How to move from bench to bedside

J 2016

c-MET-mediated resistance to EGFR inhibitors in head and neck cancer: How to move from bench to bedside

SZTURZ, Petr, E. RAYMOND a S. FAIVRE

Základní údaje

Originální název

c-MET-mediated resistance to EGFR inhibitors in head and neck cancer: How to move from bench to bedside

Autoři

SZTURZ, Petr (203 Česká republika, garant, domácí), E. RAYMOND (250 Francie) a S. FAIVRE (250 Francie)

Vydání

Oral oncology, AMSTERDAM, ELSEVIER SCIENCE BV, 2016, 1368-8375

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 4.794

Kód RIV

RIV/00216224:14110/16:00090826

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1016/j.oraloncology.2016.05.017

UT WoS

000380544000005

Klíčová slova anglicky

squamous-cell carcinoma; randomized phase-ii; tivantinib arq 197; lung-cancer; acquired-resistance; metastatic head; plus erlotinib; double-blind; patients pts; placebo

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 15. 9. 2016 15:09, Soňa Böhmová

Anotace

V originále

Mesenchymal–epithelial transition factor (c-MET), found on melanocytes, endothelial cells, and epithelial tissues, is a membrane spanning receptor tyrosine kinase for hepatocyte growth factor (HGF), produced by elements of mesenchymal origin. The receptor-ligand pair controls diverse biological activities including cell proliferation, motility, invasiveness, morphogenesis, apoptosis, and angiogenesis.

Citovat

SZTURZ, Petr, E. RAYMOND a S. FAIVRE. c-MET-mediated resistance to EGFR inhibitors in head and neck cancer: How to move from bench to bedside. Oral oncology. AMSTERDAM: ELSEVIER SCIENCE BV, 2016, roč. 59, AUG 2016, s. "E12"-"E14", 3 s. ISSN 1368-8375. Dostupné z: https://dx.doi.org/10.1016/j.oraloncology.2016.05.017.

@article{1354105,
   author = {Szturz, Petr and Raymond, E. and Faivre, S.},
   article_location = {AMSTERDAM},
   article_number = {AUG 2016},
   doi = {http://dx.doi.org/10.1016/j.oraloncology.2016.05.017},
   keywords = {squamous-cell carcinoma; randomized phase-ii; tivantinib arq 197; lung-cancer; acquired-resistance; metastatic head; plus erlotinib; double-blind; patients pts; placebo},
   language = {eng},
   issn = {1368-8375},
   journal = {Oral oncology},
   title = {c-MET-mediated resistance to EGFR inhibitors in head and neck cancer: How to move from bench to bedside},
   url = {http://www.sciencedirect.com/science/article/pii/S136883751630063X},
   volume = {59},
   year = {2016}
}

TY  - JOUR
ID  - 1354105
AU  - Szturz, Petr - Raymond, E. - Faivre, S.
PY  - 2016
TI  - c-MET-mediated resistance to EGFR inhibitors in head and neck cancer: How to move from bench to bedside
JF  - Oral oncology
VL  - 59
IS  - AUG 2016
SP  - "E12"-"E14"
EP  - "E12"-"E14"
PB  - ELSEVIER SCIENCE BV
SN  - 13688375
KW  - squamous-cell carcinoma
KW  - randomized phase-ii
KW  - tivantinib arq 197
KW  - lung-cancer
KW  - acquired-resistance
KW  - metastatic head
KW  - plus erlotinib
KW  - double-blind
KW  - patients pts
KW  - placebo
UR  - http://www.sciencedirect.com/science/article/pii/S136883751630063X
N2  - Mesenchymal–epithelial transition factor (c-MET), found on melanocytes, endothelial cells, and epithelial tissues, is a membrane spanning receptor tyrosine kinase for hepatocyte growth factor (HGF), produced by elements of mesenchymal origin. The receptor-ligand pair controls diverse biological activities including cell proliferation, motility, invasiveness, morphogenesis, apoptosis, and angiogenesis.
ER  -

SZTURZ, Petr, E. RAYMOND a S. FAIVRE. c-MET-mediated resistance to EGFR inhibitors in head and neck cancer: How to move from bench to bedside. \textit{Oral oncology}. AMSTERDAM: ELSEVIER SCIENCE BV, 2016, roč.~59, AUG 2016, s.~''E12''-''E14'', 3 s. ISSN~1368-8375. Dostupné z: https://dx.doi.org/10.1016/j.oraloncology.2016.05.017.

Podrobný výpis o publikaci